• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素疗法对绝经期间阴道生理的影响。

Effects of estrogen therapy on vaginal physiology during menopause.

作者信息

Semmens J P, Tsai C C, Semmens E C, Loadholt C B

出版信息

Obstet Gynecol. 1985 Jul;66(1):15-8.

PMID:2989746
Abstract

Vaginal physiology was evaluated in 23 postmenopausal women before estrogen replacement therapy and at 1, 3, 6, 12, 18, and 24 months while receiving conjugated equine estrogens (Premarin). Reversal of hormonal levels (17 beta-estradiol, gonadotropins) and vaginal cytology occurred within one month. Vaginal pH levels significantly decreased from a baseline mean of 5.2 to a level of 4.2 at 24 months (P less than .05). Women who were sexually active showed a greater decline in pH levels than did women who were sexually inactive. Maximum increases in amount of vaginal fluid and potassium levels were observed after three months of therapy. Vaginal blood flow and vaginal electropotential difference were significantly increased over baseline values at one month and again at 12 months (P less than .05) with a slow progressive improvement continuing throughout 24 months of estrogen replacement therapy. This study provides documented laboratory evidence to suggest that restoration of vaginal tissue function requires 18 to 24 months and explains why dyspareunia may persist in the early months of replacement therapy despite hormonal and cytologic return to premenopausal values.

摘要

对23名绝经后女性在接受结合马雌激素(倍美力)进行雌激素替代治疗前以及治疗1、3、6、12、18和24个月时的阴道生理状况进行了评估。激素水平(17β - 雌二醇、促性腺激素)和阴道细胞学在1个月内发生了逆转。阴道pH值从基线平均值5.2显著下降至24个月时的4.2(P < 0.05)。有性生活的女性pH值下降幅度大于无性生活的女性。治疗3个月后观察到阴道液量和钾水平的最大增加。阴道血流量和阴道电位差在1个月时显著高于基线值,在12个月时再次显著升高(P < 0.05),在整个24个月的雌激素替代治疗过程中持续缓慢进展性改善。本研究提供了有记录的实验室证据,表明阴道组织功能的恢复需要18至24个月,并解释了为什么尽管激素和细胞学指标恢复到绝经前水平,但性交困难在替代治疗的最初几个月仍可能持续存在。

相似文献

1
Effects of estrogen therapy on vaginal physiology during menopause.雌激素疗法对绝经期间阴道生理的影响。
Obstet Gynecol. 1985 Jul;66(1):15-8.
2
Estrogen deprivation and vaginal function in postmenopausal women.绝经后女性的雌激素缺乏与阴道功能
JAMA. 1982 Jul 23;248(4):445-8.
3
The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.在泰国绝经后女性中经阴道使用两种雌激素制剂(复方避孕药与结合雌激素乳膏)治疗泌尿生殖系统症状的比较研究。
Clin Pharmacol Ther. 1998 Aug;64(2):204-10. doi: 10.1016/S0009-9236(98)90154-0.
4
Effect of raloxifene on sexual function in postmenopausal women.雷洛昔芬对绝经后女性性功能的影响。
Climacteric. 2003 Sep;6(3):248-56.
5
Vaginal physiology in postmenopausal women: pH value, transvaginal electropotential difference, and estimated blood flow.
South Med J. 1987 Aug;80(8):987-90. doi: 10.1097/00007611-198708000-00013.
6
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.接受醋酸炔诺酮与低剂量炔雌醇联合治疗的绝经后女性与接受结合马雌激素与醋酸甲羟孕酮联合治疗的绝经后女性相比,阴道出血减少。
Am J Obstet Gynecol. 2003 Jan;188(1):92-9. doi: 10.1067/mob.2003.104.
7
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Obstet Gynecol. 1984 Jan;63(1):1-5.
8
Decreased circulating levels of estrogen alter vaginal and clitoral blood flow and structure in the rabbit.家兔体内雌激素循环水平降低会改变其阴道和阴蒂的血流及结构。
Int J Impot Res. 2001 Apr;13(2):116-24. doi: 10.1038/sj.ijir.3900655.
9
The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.雌激素加孕激素替代疗法对绝经后女性脂蛋白[a]水平的降低作用。
Arch Intern Med. 1993 Jun 28;153(12):1462-8.
10
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.替勃龙、经皮雌二醇或口服雌激素 - 孕激素疗法:对循环中别孕烯醇酮、皮质醇和脱氢表雄酮水平的影响。
Gynecol Endocrinol. 2005 Mar;20(3):144-9. doi: 10.1080/09513590400021169.

引用本文的文献

1
Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.绝经后妇女使用低剂量阴道雌激素的子宫内膜安全性:系统证据评价。
Menopause. 2019 Jul;26(7):800-807. doi: 10.1097/GME.0000000000001315.
2
Immunolocalization of steroidogenic enzymes in the vaginal mucous of Galea spixii during the estrous cycle.动情周期中斯氏原鼠阴道黏液中类固醇生成酶的免疫定位
Reprod Biol Endocrinol. 2017 Apr 24;15(1):30. doi: 10.1186/s12958-017-0248-3.
3
Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition.
在绝经过渡期间,自慰频率和性功能领域与血清生殖激素水平相关。
J Clin Endocrinol Metab. 2015 Jan;100(1):258-66. doi: 10.1210/jc.2014-1725.
4
Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women.口服LCR 35全冻干培养物对健康女性阴道的影响。
Infect Dis Obstet Gynecol. 2012;2012:503648. doi: 10.1155/2012/503648. Epub 2012 Jun 4.
5
Local Effects of Vaginally Administered Estrogen Therapy: A Review.经阴道给予雌激素疗法的局部效应:综述
J Pelvic Med Surg. 2009 May;15(3):105-114. doi: 10.1097/SPV.0b013e3181ab4804.
6
Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women.系统和局部激素治疗可降低绝经后妇女的阴道神经密度。
Menopause. 2012 Jun;19(6):630-5. doi: 10.1097/gme.0b013e31823b8983.
7
Dyspareunia in postmenopausal women: a critical review.绝经后女性性交困难:一项批判性综述。
Pain Res Manag. 2008 May-Jun;13(3):243-54. doi: 10.1155/2008/269571.
8
The rationale for low-dose hormonal therapy.低剂量激素疗法的基本原理。
Endocrine. 2004 Aug;24(3):217-21. doi: 10.1385/ENDO:24:3:217.
9
Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women.真性压力性尿失禁女性阴道前壁中雌激素受体α和β的表达
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Oct;14(4):276-81; discussion 281. doi: 10.1007/s00192-003-1042-7. Epub 2003 Aug 2.
10
Distribution of estrogen receptors alpha and beta mRNA in mouse urogenital tissues and their expression after oophorectomy and estrogen replacement.雌激素受体α和β mRNA在小鼠泌尿生殖组织中的分布及其在卵巢切除和雌激素替代后的表达。
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Jun;14(2):141-5. doi: 10.1007/s00192-002-1020-5. Epub 2003 Feb 27.